ABD Boards During COVID: What’s your plan of attack?
As recent dermatology residency graduates like myself are well aware, the landscape is set – we will be taking our boards in October. Admittedly, when the ABD (American Board of Dermatology) inquired about when residents would like to take the exam, I responded – “July, please”. But as an entity that must look out for the interests of everyone while navigating the challenges of this pand …
As recent dermatology residency graduates like myself are well aware, the landscape is set – we will be taking our boards in October. Admittedly, when the ABD (American Board of Dermatology) inquired about when residents would like to take the exam, I responded – “July, please”. But as an entity that must look out for the interests of everyone while navigating the challenges of this pand … Continue reading "ABD Boards During COVID: What’s your plan of attack?"
Tomorrow when we arrive into clinic (or this afternoon if you are reading this during your lunch break), we will invariably be greeted with patients who struggle with one of the most common diseases we treat – acne. More than likely, we will reach for topical retinoids, topical antibiotics, and the occasional systemic antibiotic. Evidence supports the short-term use of systemic antibiotics t … 
You are at the end of a busy afternoon clinic, with only a single patient standing between you and freedom to go visit a good friend and watch the Stanley Cup playoffs, of course after completing a metric ton of electronic charting. The chart in the door (or more likely on the EMR tablet) says “CHIEF COMPLAINT: ACNE”. Do you smile or groan? Acne vulgaris, or “common” acne, is itself among … 
Dr. Jeffrey S. Dover, in partnership with the Journal of Drugs in Dermatology, invited a panel of dermatology Key Opinion Leaders to share their experience as they reopen their practices during the COVID-19 pandemic. If you missed the previous videos in the series, you can watch them here. We conclude the series with dermatologic surgeon Dr. Thomas E. Rohrer, one of the nation’s leading exper … 
Dr. Jeffrey S. Dover, in partnership with the Journal of Drugs in Dermatology, invited a panel of dermatology Key Opinion Leaders to share their experience as they reopen their practices during the COVID-19 pandemic. If you missed the previous videos in the series, you can watch them here. We continue the series with Dr. Terrence Keaney, co-founder of SkinDC, a private practice in the Washingto …